Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.0500 (2.32%) ($100.6500 - $104.0100) on Tue. Apr. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.42% (three month average) | RSI | 31 | Latest Price | $103.0500(2.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -5.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(59%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.71% in a week (0% probabilities). VIXM(-24%) UUP(-20%) VXX(-16%) TBT(-7%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.71% (StdDev 3.42%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $97.29(-5.59%) | Resistance Level | $111.06 | 5 Day Moving Average | $104.89(-1.75%) | 10 Day Moving Average | $107.43(-4.08%) | 20 Day Moving Average | $111.06(-7.21%) | To recent high | -17.6% | To recent low | 8.1% | Market Cap | $1.656b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |